study of the Drug Sagala vaaivu kutthaluku kiyazham in patients having Lumbar spondylosis

An open comparative clinical evaluation on Thandaga vatham(lumbar spondylosis) with Siddha herbal formulation drug Sagala vaaivu kutthaluku kiyazham internal Iduppuvali muthalia vaaivukaluku pattru external and yoga therapy . - Svkk

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/013638

Enrollment

Registered

2018-05-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Thandaga vatham (Lumbar spondylosis)

Interventions

Intervention1: Yoga therapy: Salabhasanam puyangasanam Setubandhasanam Intervention2: Iduppuvali muthalia vaaivukaluku pattru: 20 grams of Iduppuvali muthalia vaaivukaluku pattru powder with juice of

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients having any one of the symptoms of lower back pain radiates to the lower extremities anteriorly tenderness numbness 2 Limitation of lower back movements 3 Patients willing yo sign consent form

Exclusion criteria

Exclusion criteria: 1 Patients age below 35 and above 60 years 2 Traumatic condition 3 Ankylosing spondylitis 4 Spondylolisthesis 5 Neoplasm 6 pregnant women 7 Cardiac diseases 8 Lactating mother 9 Congenital anomalies 10 Potts disease

Design outcomes

Secondary

Measure	Time frame
Secondary outcome is assessed by comparing the safety parameters before and after treatmentTimepoint: 48 days	—

Primary

Measure	Time frame
1 Pain reduction is evidenced by pain assessment scale 2 Reduction of stiffness and pain present in the lumbar regions 3 Improvements in the range of movements of lumbar regions 4 Improvements in ability to sit stand and walk for a long time without painTimepoint: 48 days	—

Countries

India

Contacts

Public ContactDr Shasikala

Government siddha medical college

spmhibiscus@gmail.com9444190077

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026